Subgroup Efficacy Analysis
Subgroup Efficacy Analysis is a statistical method used in clinical trial evaluation that assesses the effectiveness of a drug within specific subpopulations of patients defined by particular characteristics, thereby identifying differential treatment effects across subgroups while maintaining rigorous control for multiplicity and bias.
65
Publications
3.6K
Citations
631
Authors
325
Institutions
Publications per year
2017–2026
25
Parents
65
1–5 of 65
631
3
h-index
3
h-index
2
h-index
2
h-index
2
h-index
1–5 of 631
325
The Ohio State University
Columbus, United States
5 h-index
6 publications
130 citations
The University of Texas MD Anderson Cancer Center
Houston, United States
4 h-index
7 publications
193 citations
Eli Lilly (United States)
Indianapolis, United States
4 h-index
8 publications
172 citations
Novartis (Switzerland)
Basel, Switzerland
4 h-index
13 publications
784 citations
University Medical Center Utrecht
Utrecht, The Netherlands
3 h-index
5 publications
129 citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
3 h-index
7 publications
281 citations

Cornell University
Ithaca, United States
3 h-index
3 publications
171 citations
University of Pittsburgh
Pittsburgh, United States
3 h-index
4 publications
85 citations
1–8 of 325
7 publications · 379 citations
7
h-index
3 publications · 44 citations
3
h-index
2 publications · 687 citations
2
h-index
SBR · 2 publications · 106 citations
2
h-index
2 publications · 63 citations
2
h-index
1–5